Surgery As Needed for Oesophageal Cancer - 2
ConditionCancer of Esophagus
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorBas P. L. Wijnhoven
About this trial
A prospective cohort study on active surveillance after neoadjuvant chemoradiation for oesophageal cancer: SANO-2 study.
Eligibility criteria
Qualifiers
Operable patients who are planned to undergo or who recently underwent neoadjuvant chemoradiotherapy according to CROSS followed by surgical resection for histologically proven oesophageal squamous cell carcinoma or adenocarcinoma of the oesophagus or oesophago-gastric junction
Age ≥18
Written, voluntary, informed consent.
Disqualifiers
Non-FDG-avid tumour at baseline PET-CT scan
Initial treatment with endoscopic resection
Patients who underwent of who are planned to undergo definitive chemoradiotherapy
Language difficulty, dementia or altered mental status prohibiting the understanding and giving of informed consent.
Trial design
Treatments tested in this trial
- Active surveillance
Treatment groups
No treatment groups listed
Sponsors and collaborators
Bas P. L. Wijnhoven
Lead sponsor
Erasmus Medical Center
Sponsor institution
Source ClinicalTrials.gov